格式化内容附注: | Overview of gynecologic cancers / Ikbal Kaygusuz, MD, Aydin Kosus, MD, and Hasan Kafali, MD -- Cytogenetic early markers in gynecologic cancers / Murat Oznur, MD, PhD, Serap Dede, MS, Debmalya Barh, MSc, MTech, MPhil, PhD, and Mehmet Gunduz, MD, PhD -- Early biomarkers in breast cancer / Ruchika Kaul-Ghanekar, MSc, PhD, Snehal Suryavanshi, MSc, and Prerna Raina, MSc -- Diagnostic and prognostic markers of breast invasive lesions / Maria C. Calomarde, MD, Carlos Iglesias, MD, Elisa Moreno-Palacios, MD, Javier De Santiago, MD, PhD, and Ignacio Zapardiel, MD, PhD -- Biomarkers for early detection of familial breast cancer / Burak Yilmaz, MS, Catherine A. Moroski-Erkul, MS, Omer Faruk Hatipoglu, PhD, Esra Gunduz, DMD, PhD, Debmalya Barh, MSc, MTech, MPhil, PhD, and Mehmet Gunduz, MD, PhD -- DNA methylation : an epigenetic marker of breast cancer influenced by nutrients acting as an environmental factor / Tarique N. Hasan, MSc, Gowhar Shafi, PhD, B. Leena Grace, PhD, Jesper Tegner, PhD, and Anjana Munshi, PhD -- Biomarkers for early detection of cervical cancer / Ruchika Kaul-Ghanekar, MSc, PhD, Amit S. Choudhari, MSc, and Savita Pandita, MSc -- Biomarkers in cervical cancer: DNA HR-HPV, p16INK4a, Ki-67, and RNA-m E6/E7 / María Serrano, MD, María-Dolores Diestro, MD, PhD, Marcos Cuerva, MD, PhD, Ignacio Zapardiel, MD, PhD, Adolfo Loayza, MD, PhD, Alicia Hernández, MD, PhD, and Javier De Santiago, MD, PhD -- Biomarkers of nucleotide metabolism in cervical cancer / Charles A. Kunos, MD, PhD, Lauren Shunkwiler, BA, and Gina Ferris, BA -- Noninvasive early biomarkers in ovarian cancer / Sharon A. O'Toole, MSc, PhD, Eugen Ancuta, MSc, MD, PhD, Ream Langhe, MB CHB, MSc, Dolores J. Cahill, PhD, Mairead Murphy, PhD, Cara Martin, MSc, PhD, Lynda McEvoy, PhD, Cathy Spillane, PhD, Orla Sheils, MA, PhD, Emmanuel Petricoin, PhD, Lance Liotta, MD, PhD, and John J. O'Leary, MD, MB, BCh, BAO, BSc, MSc, DPhil -- Biomarkers in ovarian endometrioid carcinoma / Murat Oznur, MD, PhD, Serap Memik, MS, Mehmet Gunduz, MD, PhD, and Esra Gunduz, DMD, PhD -- MUC16/CA125 : a candidate tumor marker for diagnosis and therapy in ovarian cancer / Houda Bouanene, PhD, and Jemni Ben Chibani, PhD -- Role of HE4 in the management of ovarian cancer / Daniel Abehsera, MD, PhD, Javier De Santiago, MD, PhD, and Ignacio Zapardiel, MD, PhD -- Biomarkers in endometrial cancer / Gokhan Nas, MS, Tugce Yasar, MS, Mehmet Gunduz, MD, PhD, and Esra Gunduz, DMD, PhD -- Biomarkers in uterine mesenchymal and mixed malignant tumors / Rosario Rivera Buery, DMD, PhD, and Esra Gunduz, DMD, PhD -- Noninvasive early biomarkers in fallopian tube carcinoma / Panagiotis Peitsidis, MSc, PhD -- Biomarkers for early detection of vaginal cancers / Zeynep Ocak, MD, Muradiye Acar, PhD, Mehmet Gunduz, MD, PhD, and Esra Gunduz, DMD, PhD -- Noninvasive early biomarkers for vulvar cancer / Sara Iacoponi, MD, PhD, Marcos Cuerva, MD, PhD, Mar Gil, MD, Elisa Moreno-Palacios, MD, Alicia Hernández, MD, PhD, Javier de Santiago, MD, PhD, and Ignacio Zapardiel, MD, PhD. |